Stephen Ruedrich: Clinical Trials

1 trial sponsored by Stephen Ruedrich, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Withdrawn 1

Follow Stephen Ruedrich: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities
Valbenazine Oral Capsule - Tardive Dyskinesia, Intellectual Disability
Phase 4WithdrawnStephen Ruedrich2025-01-012024-10-24

Conditions studied

Caregiver Burden (1)  ·  Developmental Disabilities (1)  ·  Intellectual Disability (1)  ·  Movement Disorders (1)  ·  Tardive Dyskinesia (1)

Interventions

valbenazine (1)

Countries

United States (1)